Related Experiment Video
Updated: Jun 12, 2026
An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
Oncologic photodynamic therapy photosensitizers: a clinical review
Ron R Allison1, Claudio H Sibata
121st Century Oncology, Greenville, NC 27834-3764, USA.
Abstract:
A myriad of naturally occurring and synthetic structures are capable of transferring the energy of light. Few, however, allow for this energy transfer to enable a type II photochemical reaction which, as currently practiced, is a fundamental component of photodynamic therapy. Even fewer of these agents, aptly termed photosensitizers, have found success in the treatment of patients. This review will focus on the oncologic photosensitizers that have come to clinical trial with outcomes published in peer reviewed journals. Based on a clinical orientation the qualities of successful photosensitizers will be examined, how current drugs fare and potential future options explored.
Insights
This review examines photosensitizers for cancer treatment. It focuses on agents used in clinical trials, evaluating their success and future potential in photodynamic therapy.
Area of Science:
- Photochemistry
- Oncology
- Photodynamic Therapy
Background:
- Light-energy transferring molecules are abundant.
- Type II photochemical reactions are crucial for photodynamic therapy (PDT).
- Few photosensitizers have achieved clinical success in treating patients.
Purpose of the Study:
- To review oncologic photosensitizers that have undergone clinical trials.
- To examine the characteristics of successful photosensitizers based on clinical outcomes.
- To explore the performance of current photosensitizers and future therapeutic options.
Main Methods:
- Literature review of peer-reviewed journals.
- Focus on photosensitizers with published clinical trial outcomes.
- Clinical evaluation of photosensitizer efficacy and safety.
Main Results:
- Identified specific photosensitizers that have advanced to clinical trials for cancer treatment.
- Analyzed clinical data to determine factors contributing to photosensitizer success.
- Assessed the current standing of approved and investigational photosensitizers.
Conclusions:
- Successful photosensitizers require specific properties for effective oncologic PDT.
- Clinical data reveals variability in the performance of current photosensitizing agents.
- Future research directions aim to develop more effective and safer photosensitizers for cancer therapy.
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...